Abstract:Objective To investigate the expressions and clinical significance of the receptor for advanced glycation end‐products (RAGE ) and its ligands S100A8 and S100P in benigne prostate hypertrophy(BPH) and prostate cancer(PC) tissues .Methods Immunohistochemical method was employed to examine the expressions of RAGE and its ligands S100A8 and S100P in 32 PC patients . The expressions in BPH and PC were compared .Results The expressions of RAGE ,S100A8 and S100P in PC tissues were significantly higher than those in BPH(P<0 .05) .The expression of RAGE in PC tissues was related to prostate‐specific antigen(P<0 .05) .The expressions of RAGE ,S100A8 and S100P in PC tissues were closely related to TNM and clinical stages(P<0 .05 ) .The expression of RAGE was possitively correlated to that of S100A8 and S100P(P<0 .05) .Conclusion RAGE and its ligands S100A8 and S100P may participate in the development ,invasion and metastasis of PC and could become the targets for the diagnosis and treatment of PC .

Expressions of RAGE,S100A8 and S100P in benigne prostate hypertrophy and prostate cancer